Unit 3 · Vitamin B3 & B5
Why niacinamide is compatible with almost everything else in this module
Niacinamide earns its place in nearly every routine because it works through five independent mechanisms at once, not because it is a gentler substitute for something stronger. By the end of this unit you should be able to explain which mechanism does the work for a given presentation, and why panthenol, its B-vitamin neighbour, plays an entirely different clinical role.
Learn · Mechanisms of action
Five independent pathways, working simultaneously
Niacinamide (nicotinamide) is the biologically active amide form of vitamin B3. It is water-soluble, exceptionally stable across a wide pH range, and compatible with almost every other topical active.
It works through several independent pathways at once — which is what makes it so broadly applicable across skin types and presentations.
- Melanosome transfer inhibition
- Niacinamide does not inhibit melanin synthesis within the melanocyte. Instead, it interferes with the transfer of melanosomes — melanin-containing organelles — from melanocytes to surrounding keratinocytes. This is a distinct mechanism from most other brightening agents. Effect: reduced pigment distribution across the epidermis.
- Barrier function support
- Increases synthesis of ceramides, free fatty acids and cholesterol in the stratum corneum — the key lipids of the skin barrier. Reduces transepidermal water loss (TEWL). Effect: measurable barrier improvement within 2–4 weeks.
- Sebum regulation
- Inhibits sebaceous lipid excretion. Clinically significant reduction in sebum production at concentrations of 2–4%.
- Anti-inflammatory
- Suppresses cytokine production (TNF-α, IL-6) and reduces erythema. A key mechanism in rosacea and acne management.
- Anti-glycation
- Prevents non-enzymatic cross-linking of collagen by advanced glycation end-products (AGEs) — a lesser-discussed but significant ageing mechanism.
A colleague tells a patient that niacinamide and vitamin C cannot be used together because they react to form niacin and cause flushing. Before reading on, decide whether that guidance still holds up in current formulations.
Hold your position before you open this. The value is in having committed to a view first.
This is a longstanding claim, and it is based on an old in vitro study using concentrations far beyond those found in skincare. At typical use concentrations and modern formulation pH, the interaction is clinically negligible.
The two ingredients may be layered or combined in a single formulation without meaningful loss of efficacy for either. If a patient is still concerned, the practical answer is to apply vitamin C in the morning and niacinamide in the morning or evening separately — not to avoid the pairing altogether (Levin & Momin, 2010).
A patient with diffuse hyperpigmentation asks how niacinamide differs from other brightening actives she has tried. Niacinamide reduces hyperpigmentation primarily by:
Select an option to commit. The reasoning appears afterwards.
Niacinamide does not inhibit melanin synthesis within the melanocyte. It interferes with the transfer of melanosomes — melanin-containing organelles — from melanocytes to surrounding keratinocytes, which reduces pigment distribution across the epidermis.
This is a genuinely distinct mechanism from most other brightening agents, including vitamin C's tyrosinase inhibition covered in Unit 4. That distinction is why the two are often combined for a multi-pathway approach to pigmentation, rather than treated as interchangeable alternatives.
Learn · Matching niacinamide to presentation
Where each mechanism does the most clinical work
- Uneven skin tone / hyperpigmentation
- First-line adjunct. Clinical improvement in solar lentigines and diffuse hyperpigmentation at 4–5% over 8–12 weeks. Safe across all phototypes.
- Oily / acne-prone skin
- Sebum reduction, anti-inflammatory action and comedone prevention make niacinamide highly suitable. Concentrations of 2–4% for sebum; 5%+ for pigmentation.
Sensitive / rosacea-prone skin: the anti-inflammatory and barrier-repairing properties make niacinamide one of the few actives appropriate for active rosacea. It is unlikely to trigger flares and is typically very well tolerated.
Dry / compromised barrier: ceramide synthesis stimulation supports barrier restoration, making niacinamide a strong candidate in post-procedure protocols.
Fitzpatrick IV–VI: one of the safest brightening options for darker skin types. No known risk of PIH and no irritation at standard concentrations (2–10%) — highly recommended as the backbone of PIH management protocols.
A patient with oily, acne-prone skin and mild diffuse pigmentation wants a single niacinamide product to address both concerns. Based on the concentration thresholds described, the most useful guidance is:
Select an option to commit. The reasoning appears afterwards.
Sebum regulation is clinically significant at 2–4%, while meaningful improvement in solar lentigines and diffuse hyperpigmentation is described at 4–5% and above. A single product can plausibly do both if it sits in the higher part of that range, but the concentration on the label is the detail that determines which outcome is realistic.
This is a useful habit generally: niacinamide's broad tolerability can make it easy to assume any formulation will do everything it is capable of. The mechanism is versatile; the dose still has to match the goal.
Learn · Vitamin B5: panthenol & dexpanthenol
The recovery active, not the correction active
Panthenol (provitamin B5, or D-panthenol) is the alcohol analogue of pantothenic acid. It is converted in the skin to pantothenic acid, a component of coenzyme A — required for fatty acid synthesis and energy metabolism in keratinocytes. In aesthetic medicine, panthenol is primarily valued as a potent humectant, barrier-repair agent, and post-procedure recovery ingredient.
- Humectant
- Attracts and retains water in the stratum corneum. Effective as a standalone hydrating agent and in combination with other humectants — hyaluronic acid, glycerin.
- Barrier repair
- Supports synthesis of keratinocyte lipids. Accelerates re-epithelialisation in studies of minor wound healing. Reduces TEWL.
- Anti-inflammatory
- Measurable reduction in erythema and itch — relevant in post-laser and post-peel contexts.
- Wound healing support
- Multiple studies demonstrate accelerated re-epithelialisation in superficial wounds treated with dexpanthenol — particularly relevant following ablative resurfacing, chemical peels or microneedling.
Recommend panthenol in the first 7 days post-ablative or semi-ablative procedures as part of a simplified barrier-recovery protocol — no actives, just panthenol, a gentle cleanser, and SPF. Well tolerated, non-irritating and non-comedogenic across all Fitzpatrick phototypes, with no known photosensitivity.
A patient is on day 3 after ablative laser resurfacing and asks what she should be using on her skin. Based on the barrier-recovery role of panthenol, the appropriate guidance is:
Select an option to commit. The reasoning appears afterwards.
Panthenol's primary use case in aesthetic medicine is post-procedure recovery. It accelerates re-epithelialisation, reduces erythema and supports barrier recovery, and the recommended approach in the first 7 days post-ablative or semi-ablative procedure is a deliberately simplified protocol: panthenol, a gentle cleanser and SPF — no other actives.
Day 3 sits inside that first-week window, where re-epithelialisation is still under way. Introducing a correcting active before the barrier has recovered adds irritation risk at exactly the point the skin is least able to tolerate it — the sequencing matters as much as the ingredient choice.
Unit 3 summary
Clinical takeaways
- Niacinamide works through five independent mechanisms at once. Pigment, barrier, sebum, inflammation and glycation pathways all respond, which is why it fits almost every routine rather than one specific presentation.
- Its pigment mechanism is distinct from vitamin C's. Niacinamide blocks melanosome transfer rather than inhibiting tyrosinase — a genuinely different route to the same clinical outcome.
- The niacinamide and vitamin C flushing concern is outdated. It derives from a supraphysiological in vitro study; at real-world skincare concentrations the two can be layered or combined without meaningful loss of efficacy.
- Panthenol is a recovery active, not a correction active. It converts to pantothenic acid, a coenzyme A component, and its clearest role in aesthetic medicine is the deliberately simplified first-week barrier-recovery protocol after ablative or semi-ablative procedures.